Quarterly report pursuant to Section 13 or 15(d)

Goodwill - Additional Information (Detail)

v3.8.0.1
Goodwill - Additional Information (Detail)
 3 Months Ended 9 Months Ended
Jul. 12, 2017
USD ($)
Sep. 30, 2015
USD ($)
Aug. 31, 2017
USD ($)
Aug. 31, 2016
USD ($)
Aug. 31, 2017
USD ($)
$ / Unit
Aug. 31, 2016
USD ($)
Nov. 30, 2016
USD ($)
Goodwill [Line Items]              
Note payable to seller     $ 8,000,100   $ 8,000,100   $ 10,150,100
Goodwill impairment charge       $ 1,666,430   $ 1,666,430 111,392
Goodwill     0   0   0
PrepaCyte CB [Member]              
Goodwill [Line Items]              
Royalty expense       $ 8,425   $ 22,755  
Goodwill impairment charge             $ 1,777,822
Asset Purchase Agreement [Member]              
Goodwill [Line Items]              
Asset Purchase Agreement, purchase price less cash and prepaids         2,400,000    
Asset Purchase Agreement, cash and inventory paid     1,553,272   1,553,272    
Note payable to seller     1,300,000   $ 1,300,000    
Royalty payment per bag set unit sold | $ / Unit         5    
Royalty expense $ 100,000   94,800   $ 112,830    
Remaining Future Royalty Payments     $ 0   0    
Asset Purchase Agreement [Member] | Minimum [Member]              
Goodwill [Line Items]              
Royalty expense         35,000    
Asset Purchase Agreement [Member] | CytoMedical [Member]              
Goodwill [Line Items]              
Asset Purchase Agreement, cash paid   $ 586,675     $ 966,597